Tanaka, A., Shibata, H., Imai, T., Yoshida, H., Miyazono, M., Takahashi, N., . . . investigators, t. F. t. (2023). Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR). BMC.
Chicago Style (17th ed.) CitationTanaka, Atsushi, et al. Rationale and Design of an Investigator-initiated, Multicenter, Prospective, Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in Type 2 Diabetes and Chronic Kidney Disease (FIVE-STAR). BMC, 2023.
MLA (9th ed.) CitationTanaka, Atsushi, et al. Rationale and Design of an Investigator-initiated, Multicenter, Prospective, Placebo-controlled, Double-blind, Randomized Trial to Evaluate the Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in Type 2 Diabetes and Chronic Kidney Disease (FIVE-STAR). BMC, 2023.